Global Genomics and Proteomics Analytical Instruments Market 2014-2018

97 pages report Published in
Biotechnology
Publisher: Infiniti Research Limited

arrowFor This Report

Genomics is the study of the gene and its functions and proteomics is the study of the structure and functions of proteomes or sets of proteins by using molecular biology and bioinformatics tools and technology. Genomics involves the mapping of genes and DNA sequencing to understand the structure and functions of genomes. A proteome is a complete set of proteins expressed by a genome at a certain time. Proteomics primarily involves the use of molecular biology, biochemistry, and genetics to analyze proteins produced by genes through the translation process. Proteins are the primary component of all cells and are responsible for the various functional characteristics of cells. A defect in the genome or proteome structure or function could result in disorders. Thus, genomics and proteomics technologies play an important role in research, drug discovery, and disease diagnosis, which require the identification and study of the defective genome or proteins. It requires various instruments, reagents, and software for protein isolation, purification, identification, quantification, and analysis of the genome and proteome. There are several analytical instruments used for genomics and proteomics, but the instruments most widely used are chromatography systems, mass spectrometers, Polymerase Chain Reaction systems, and Next-generation Sequencing systems.

TechNavio’s analysts forecast the Global Genomics and Proteomics Analytical Instruments market will grow at a CAGR of 7.83 percent over the period 2013-2018.

Covered in this Report

The Global Genomics and Proteomics Analytical Instruments market can be divided into four segments: Chromatography, Polymerase Chain Reaction, Mass Spectrometry, and Next-generation Sequencing. This report covers the present scenario and the growth prospects of the Global Genomics and Proteomics Analytical Instruments market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of analytical instruments in the above four segments.

TechNavio’s report, the Global Genomics and Proteomics Analytical Instruments Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Genomics and Proteomics Analytical Instruments market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.

Other Prominent Vendors

  • Becton Dickinson and Co.
  • Bruker Corp.
  • GE Healthcare
  • Jasco Inc.
  • Jeol Ltd.
  • Luminex Corp.
  • Qiagen NV
  • Rigaku Corp.
  • Shimadzu Corp.
  • Sigma Aldrich Co. LLC
  • Spectrolab Systems
  • Waters Corp.

Key Market Driver

  • Advances in Genomics and Proteomics Technology
  • For a full, detailed list, view our report.

Key Market Challenge

  • Lack of Knowledge of Genomics and Proteomics
  • For a full, detailed list, view our report.

Key Market Trend

  • Focus on Drug Discovery and Disease Diagnosis
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Market Segmentation by Technology
07.1 Global Chromatography Instruments Market
07.1.1 Market Size and Forecast
07.2 Global PCR Instruments Market
07.2.1 Market Size and Forecast
07.3 Global Mass Spectrometry Instruments Market
07.3.1 Market Size and Forecast
07.4 Global NGS Instruments Market
07.4.1 Market Size and Forecast

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Vendor Analysis 2013
16.3 Other Prominent Vendors

17. Key Vendor Analysis
17.1 Agilent Technologies Inc.
17.1.1 Key Facts
17.1.2 Business Overview
17.1.3 Business Segmentation by Revenue 2013
17.1.4 Business Segmentation by Revenue 2012 and 2013
17.1.5 Sales by Geography
17.1.6 Business Strategy
17.1.7 Key Information
17.1.8 SWOT Analysis
17.1.9 Strengths
17.1.10 Weaknesses
17.1.11 Opportunities
17.1.12 Threats
17.2 Bio-Rad Laboratories
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation by Revenue 2012
17.2.4 Business Segmentation by Revenue 2012 and 2011
17.2.5 Geographical Segmentation by Revenue 2012
17.2.6 Business Strategy
17.2.7 Recent Developments
17.2.8 SWOT Analysis
17.2.9 Strengths
17.2.10 Weakness
17.2.11 Opportunities
17.2.12 Threats
17.3 F. Hoffmann La Roche Ltd.
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Business Segmentation
17.3.4 Business Segmentation by Revenue 2012 and 2013
17.3.5 Sales by Geography
17.3.6 Business Strategy
17.3.7 Key Information
17.3.8 SWOT Analysis
17.3.9 Strengths
17.3.10 Weaknesses
17.3.11 Opportunities
17.3.12 Threats
17.4 Illumina Inc.
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Business Segmentation
17.4.4 Sales by Geography
17.4.5 Business Strategy
17.4.6 Key Information
17.4.7 SWOT Analysis
17.4.8 Strengths
17.4.9 Weaknesses
17.4.10 Opportunities
17.4.11 Threats
17.5 PerkinElmer
17.5.1 Key Facts
17.5.2 Business Overview
17.5.3 Business Segmentation by Revenue 2013
17.5.4 Business Segmentation by Revenue 2012 and 2013
17.5.5 Business Strategy
17.5.6 Key Developments
17.5.7 SWOT Analysis
17.5.8 Strengths
17.5.9 Weaknesses
17.5.10 Opportunities
17.5.11 Threats
17.6 Thermo Fisher Scientific Inc.
17.6.1 Key Facts
17.6.2 Business Overview
17.6.3 Business Segmentation by Revenue
17.6.4 Product Segmentation by Revenue
17.6.5 Sales by Geography
17.6.6 Business Strategy
17.6.7 Key Information
17.6.8 SWOT Analysis
17.6.9 Strengths
17.6.10 Weaknesses
17.6.11 Opportunities
17.6.12 Threats

18. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Genomics and Proteomics Analytical Instruments Market 2013-2018 (US$ million)
Exhibit 3: Global Genomics and Proteomics Analytical Instruments market by Technology
Exhibit 4: Chromatography : Segmentation by Technology
Exhibit 5: Polymerase Chain Reaction: Segmentation by Technology
Exhibit 6: Mass Spectrometry : Segmentation by Technology
Exhibit 7: Global Genomics and Proteomics Analytical Instruments Market: Segmentation by Technology 2013
Exhibit 8: Global Chromatography Instruments Market 2013-2018 (US$ million)
Exhibit 9: Global PCR Instruments Market 2013-2018 (US$ million)
Exhibit 10: Global Mass Spectrometry Instruments Market 2013-2018 (US$ million)
Exhibit 11: Global NGS Instruments Market 2013-2018 (US$ million)
Exhibit 12: Global Genomics and Proteomics Analytical Instruments Market: Segmentation by Geography 2013
Exhibit 13: Agilent Technologies Inc.: Business Segmentation by Revenue 2013
Exhibit 14: Agilent Technologies Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 15: Agilent Technologies Inc.: Sales by Geography 2013
Exhibit 16: Bio-Rad Laboratories: Business Segmentation by Revenue 2012
Exhibit 17: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2011 (US$ million)
Exhibit 18: Bio-Rad Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 19: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 20: F. Hoffmann-La Roche Ltd: Business Segmentation by Revenue 2012 and 2013
Exhibit 21: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 22: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Diagnostics Division)
Exhibit 23: Illumina Inc.: Business Segmentation 2013
Exhibit 24: Illumina Inc.: Sales by Geography 2013
Exhibit 25: PerkinElmer: Business Segmentation by Revenue 2013
Exhibit 26: PerkinElmer: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 27: Thermo Fisher Scientific Inc.: Business Segmentation by Revenue 2013
Exhibit 28: Thermo Fisher Scientific Inc.: Product Segmentation by Revenue 2013
Exhibit 29: Thermo Fisher Scientific Inc.: Sales by Geography 2013

Related Reports

  • Global Synthetic Biology Market 2014-2018The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce […]
  • Global Metabolomics Market 2014-2018Metabolomics or Metabonomics is the scientific study of chemical processes involving metabolites. Metabolomics has become a new experimental technique that is being widely used in biology, medicine and the environmental sciences. Metabolites are small molecules that are present in blood, urine, and tissues. The pattern, or fingerprint, of metabolites in a biological sample is used to learn about the health of organisms. The unique patterns of metabolites are widely used to diagnose […]
  • Genomics Market in the US 2014-2018The genome is the genetic material of an individual, species or organism, which is responsible for the various functional characteristics of an individual. Genomics is an important aspect of genetics and molecular biology that focuses on the study of the structure, function, and mapping of genomes. It involves various applications in functional genomics, genome sequencing, comparative genomics, and genome analysis. A defect in genome structure or function could lead to the occurrence […]
  • Gene Therapy Respiratory Insight: Pipeline Assessment, Market Trend, Technology and Competitive LandscapeSummary DelveInsight's Report: Gene Therapy Respiratory Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Respiratory Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. […]
  • Gene Therapy Dermatology Insight: Pipeline Assessment, Market Trend, Technology and Competitive LandscapeSummary DelveInsight's Report: Gene Therapy Dermatology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Dermatology Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. […]